Patent · US Active

Insertable variable fragments of antibodies and modified α1-α2 domains of NKG2D ligands, and non-natural NKG2D ligands that bind non-natural NKG2D receptors

US10259858B2 · kind B2 · utility

3Cited by

0References

23Claims

0Family size

Assignee

XYPHOS BIOSCIENCES INC. · US

Inventors

Kyle Landgraf · Alameda, US
Daniel Steiger · San Francisco, US
Tarah S. Baron · South San Francisco, US
Dana M. Gebhart · San Francisco, US

Key dates

Filing date	Aug 4, 2016
Grant date	Apr 16, 2019
Priority date	—
Expiry date	Nov 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates generally to the production of polypeptides having specific antigen-binding properties of Fv domains, for example, insertable variable fragments of antibodies, and modified α1-α2 domains of NKG2D ligands.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.